University of Southern California · 2 months ago
Associate Director, Leukemia/Lymphoma Program-Associate Professor of Clinical Pediatrics Division of Hematology and Oncology-CHLA
The University of Southern California (USC) is a world-class research university and the largest private employer in Los Angeles. They are seeking an Associate Director for the Leukemia/Lymphoma Program at the Children's Hospital Los Angeles (CHLA), who will lead clinical and research activities in pediatric hematologic malignancies, develop clinical trials, and provide patient care.
EducationHigher EducationUniversities
Responsibilities
Assist in the leadership of clinical and clinical research activities in pediatric hematologic malignancies
Partner with the Leukemia/Lymphoma Program Director in program oversight
Provide patient care, develop and lead clinical trials, and further advance a leading clinical research program
Qualification
Required
Minimum of 2 years as an Assistant Professor in Pediatric Hematology-Oncology with a focus in hematologic malignancies
Desire to become a leader in clinical trial development
Membership of the USC Norris Comprehensive Cancer Center
Academic appointment through USC Keck School of Medicine at the level of Assistant Professor, Associate Professor, or Professor, appropriate to training and experience
Benefits
Strong administrative, clinical, research and financial support will be provided, including staff, infrastructure, endowments, and institutional resources.
Company
University of Southern California
University of Southern California is a private research university offering opportunities for interdisciplinary study and collaboration.
H1B Sponsorship
University of Southern California has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (253)
2024 (239)
2023 (172)
2022 (207)
2021 (182)
2020 (195)
Funding
Current Stage
Late StageTotal Funding
$19.64MKey Investors
Patient-Centered Outcomes Research InstituteCalifornia Institute for Regenerative MedicineCDA Foundation
2025-02-04Grant· $10.8M
2025-01-30Grant· $5.93M
2024-07-30Grant
Leadership Team
Recent News
Sports Business Journal
2025-12-30
Indian Express
2025-12-21
Company data provided by crunchbase